Caredx advances global transplant patient care at esot congress 2023

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a leading presence at the 2023 european society for organ transplantation (esot) congress taking place september 17-20, 2023, in athens, greece. the latest scientific advances in global transplantation using caredx's alloseq cfdna.
CDNA Ratings Summary
CDNA Quant Ranking